Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.

Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxine.

Evidence of early changes in neural plasticity may aid the prediction of rapid-onset antidepressant drugs. Here we compared the dual α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, to the SNRI, venlafaxine, with regards to their effect on rat brain expression of a pa...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Serres, F, Millan, M, Sharp, T
Formato:	Journal article
Idioma:	English
Publicado em:	2012

Registros relacionados

Serotonin syndrome triggered by postoperative administration of serotonin noradrenaline reuptake inhibitor (SNRI)
por: Junko Takata, et al.
Publicado em: (2019-08-01)

Differences between SSRI and SNRI in depression treatment
por: Mateusz Grego, et al.
Publicado em: (2025-01-01)

Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden.
por: Helga Zoega, et al.
Publicado em: (2015-01-01)

Plasma concentrations of SSRI/SNRI after bariatric surgery and the effects on depressive symptoms
por: Patrick Pasi, et al.
Publicado em: (2023-04-01)

Suicidality: risk factors and the effects of antidepressants. The example of parallel reduction of suicidality and other depressive symptoms during treatment with the SNRI, milnacipran
por: Philippe Courtet
Publicado em: (2010-08-01)

Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials
por: Helen Koechlin, et al.
Publicado em: (2021-12-01)

Folate as adjunct therapy to SSRI/SNRI for major depressive disorder: Systematic review & meta-analysis
por: Rabail Altaf, et al.
Publicado em: (2021-09-01)

Age-Dependent Analysis of Suicidal Ideation, Suicide Attempts, and Suicides Associated with SSRI and SNRI Drugs Based on Pharmacovigilance Data
por: Daria Schetz, et al.
Publicado em: (2024-12-01)

The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case–control study
por: Rosenberg T, et al.
Publicado em: (2017-11-01)

Comparação entre SNRI e SSRI na indução da remissão da perturbação depressiva major: uma revisão baseada na evidência
por: Ana Dias Amaral
Publicado em: (2014-05-01)

In-Utero SSRI and SNRI Exposure and the Risk of Neurodevelopmental Disorders in Children: A Population-Based Retrospective Cohort Study Utilizing Linked Administrative Data
por: Deepa Singal, et al.
Publicado em: (2018-09-01)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants, and antipsychotics for the human α1A, α1B, and α1D‐adrenoceptors
por: Richard G. W. Proudman, et al.
Publicado em: (2020-08-01)

Effect of venlafaxine on pineal melatonin and noradrenaline in the male rat.
por: Franklin, M, et al.
Publicado em: (1998)

The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Richard G.W. Proudman, et al.
Publicado em: (2022-04-01)

Effectiveness of Vortioxetine for the Treatment of Emotional Blunting in Patients with Major Depressive Disorder Experiencing Inadequate Response to SSRI/SNRI Monotherapy in Spain: Results from the COMPLETE Study
por: Christensen MC, et al.
Publicado em: (2024-07-01)

Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
por: Griffiths, R, et al.
Publicado em: (1999)

In-Utero SSRI and SNRI Exposure and the Risk of Long Term Adverse Mental and Educational Outcomes in Children: A Population-Based Retrospective Cohort Study Utilizing Linked Administrative Data
por: Deepa Singal, et al.
Publicado em: (2018-09-01)

Serotonin and noradrenaline reuptake inhibitors improve micturition control in mice.
por: Marco Redaelli, et al.
Publicado em: (2015-01-01)

Venlafaxine antagonizes the noradrenaline-promoted colon cancer progression by inhibiting the norepinephrine transporter
por: Huahua Zhang, et al.
Publicado em: (2023-05-01)

S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: II. A behavioral, neurochemical, and electrophysiological characterization.
por: Dekeyne, A, et al.
Publicado em: (2012)

Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
por: Kevin P. Kennedy
Publicado em: (2022-10-01)

Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.
por: Andreas Austgulen Westin, et al.
Publicado em: (2017-01-01)

Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine.
por: Hajós-Korcsok, E, et al.
Publicado em: (2000)

Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
por: Jonathan Henssler, et al.
Publicado em: (2023-05-01)

Correction: Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition.
por: Andreas Austgulen Westin, et al.
Publicado em: (2018-01-01)

β2-adrenoceptors are essential for desipramine, venlafaxine or reboxetine action in neuropathic pain
por: Ipek Yalcin, et al.
Publicado em: (2009-03-01)

S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
por: Dekeyne, A, et al.
Publicado em: (2008)

A Look at Commonly Utilized Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) in Chronic Pain
por: Christopher Robinson, et al.
Publicado em: (2022-05-01)

A Look at Commonly Utilized Serotonin Noradrenaline Reuptake Inhibitors (SNRIs) in Chronic Pain
por: Christopher Robinson, et al.
Publicado em: (2022-05-01)

The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
por: Pei, Q, et al.
Publicado em: (2004)

The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
por: Pei, Q, et al.
Publicado em: (2004)

Noradrenaline increases intracellular Ca2+ concentration in epithelial cells via α2-adrenoceptors in isolated mouse ileal crypts
por: Tomoko Kimyo, et al.
Publicado em: (2022-03-01)

Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors
por: Francisca eMeyer, et al.
Publicado em: (2014-08-01)

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models.
por: Karolina Pytka, et al.
Publicado em: (2015-01-01)

Effects of α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport.
por: Kohji Takara, et al.
Publicado em: (2012-01-01)

An fMRI study on the effects of the dopamine & noradrenaline reuptake inhibitor bupropion on reward processing in depressed individuals
por: Pickenhan, L
Publicado em: (2021)

Recent Advances in the Electrochemical Sensing of Venlafaxine: An Antidepressant Drug and Environmental Contaminant
por: Somayeh Tajik, et al.
Publicado em: (2020-06-01)

Suicide attempt with selective serotonin reuptake inhibitor antidepressants
por: Sandra Cuenca Carcelén, et al.
Publicado em: (2021-01-01)

Characterization of Noradrenaline-Induced Increases in Intracellular Ca2+ Levels in Chinese Hamster Ovary Cells Stably Expressing Human α1A-Adrenoceptor
por: Takahiro Horinouchi, et al.
Publicado em: (2007-01-01)

A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong Z, et al.
Publicado em: (2017-11-01)